JP Drafts

JP drafts for public comments, March 1 - 31, 2016

New monographs

• Calcium Levofolinate Hydrate (001-1603eng.pdf)
• Pazufloxacin Mesilate (002-1603eng.pdf)
• Pentobarbital Calcium Tablets (003-1603eng.pdf)
• Zonisamide (004-1603eng.pdf)

Ultraviolet-visible reference spectra

• Calcium Levofolinate Hydrate (005-1603eng.pdf)
• Pazufloxacin Mesilate (006-1603eng.pdf)
• Zonisamide  (007-1603eng.pdf)

Infrared reference spectra

• Calcium Levofolinate Hydrate (008-1603eng.pdf)
• Pazufloxacin Mesilate (009-1603eng.pdf)
• Zonisamide (010-1603eng.pdf)

To send the comment on these drafts, the guidance is as follows:
 

1. Download this form in Word format
2. Fill in the form
3. Prepare and attach the supportive data that scientifically validate the comment when appropriate
4. Send it to the email address: JPdraft1603eng@pmda.go.jp

Related Information

• Columns (chemical drug)
   

Note: The information provided with the comment may be released to the public whenever necessary (except the individual name, organization, address, telephone & fax numbers and e-mail address or the attached supportive data).